Ad Header



The Pulse of the Pharmaceutical Industry

  • Filter By Category

  • Filter By Author

BioMarin drug fails to show inattention, mood benefit in study

BioMarin’s genetic disorder drug met the study’s main goal of reducing a toxic buildup of an amino acid, but did not show enough benefit in related inattention and mood complications.

Read More »

Valeant Hunts for New CEO

J. Michael Pearson is out at Valeant Pharmaceuticals and the company is looking for a new chief executive officer.

Read More »

Presidential Contender Asks the U.S. Treasury to Block Pfizer’s Major Tax Evasion

U.S. Sen. Bernie Sanders called on the U.S. Department of the Treasury to block Pfizer plan to relocate overseas as part of its merger with Allergan to cut its tax burden.

Read More »

UK cost agency backs J&J cancer drug in change of heart

A cancer drug originally discovered in Britain has finally been endorsed for treating advanced prostate cancer before chemotherapy on the country’s state health service in a change of heart by the cost agency NICE.

Read More »

WHO suspends TB drugs from big India supplier on quality fears

The World Health Organization has suspended the approval of tuberculosis drugs made by India’s Svizera Labs, a major supplier to developing countries, following an investigation into standards.

Read More »

E-Commerce: Its improvement and foreseeable future views

The e-commerce may possibly be defined being a fashionable small business methodology that addresses the requires of corporations, merchants, and individuals to chop expenditures when enhancing the standard of products and products and rising the velocity of company shipping and delivery, by making use of Internet. The development of digital commerce advanced as the strategy […]

Read More »

J&J psoriasis drug Stelara eases Crohn’s disease in second trial

Johnson & Johnson’s Stelara psoriasis drug has shown effectiveness against Crohn’s disease in a second late-stage trial, bolstering prospects of its approval for the additional use.

Read More »

Brazil says confirmed and suspected microcephaly cases rise to 5,131

The number of confirmed and suspected cases of microcephaly in Brazil associated with the Zika virus has risen to 5,131 from 4,976 a week earlier, the Ministry of Health said on Friday.   Of these, the number of confirmed cases climbed to 863 from 745 a week earlier, while suspected ones increased to 4,268 from […]

Read More »

U.S. FDA rejects Eagle Pharma’s blood thinner

The U.S. Food and Drug Administration rejected Eagle Pharmaceuticals Inc.’s drug to prevent blood clots in certain patients undergoing heart surgery.

Read More »

Helsinn and Eisai Announce Revised U.S. Collaboration for CINV Franchise

Helsinn and Eisai Inc. announced a revised agreement for their chemotherapy-induced nausea and vomiting (CINV) franchise.

Read More »

Ad Right Top


Extensive pharmaceutical business and marketing intelligence. For back issues, please contact

April 2019 Focus: Healthcare agency & network profiles, industry overview & awards, and more!


Ad Right Bottom